Erstellt von conna
Apple Inc. diskutieren
Apple Inc.
WKN: 865985 / Symbol: AAPL / Name: Apple / Aktie / Computer, Telefonie & Haushaltselektronik / Large Cap /
160,60 €
0,63 %
Apple Inc. (NASDAQ: AAPL) was given a new $183.86 price target on by analysts at Fundamental Research. They now have a "buy" rating on the stock.
Ratings data for AAPL provided by MarketBeat
Apple Inc. (NASDAQ: AAPL) had its price target raised by analysts at Evercore ISI from $190.00 to $210.00. They now have an "outperform" rating on the stock.
Ratings data for AAPL provided by MarketBeat
Apple Inc. (NASDAQ: AAPL) is now covered by analysts at Citigroup Inc.. They set a "buy" rating on the stock.
Ratings data for AAPL provided by MarketBeat
Apple Inc. (NASDAQ: AAPL) had its price target raised by analysts at Morgan Stanley from $190.00 to $220.00. They now have an "overweight" rating on the stock.
Ratings data for AAPL provided by MarketBeat
Apple Inc. (NASDAQ: AAPL) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $220.00 price target on the stock.
Ratings data for AAPL provided by MarketBeat
Apple Inc. (NASDAQ: AAPL) had its price target raised by analysts at Robert W. Baird from $180.00 to $204.00. They now have an "outperform" rating on the stock.
Ratings data for AAPL provided by MarketBeat
Apple Inc. (NASDAQ: AAPL) had its price target raised by analysts at TD Cowen from $195.00 to $220.00. They now have an "outperform" rating on the stock.
Ratings data for AAPL provided by MarketBeat
Apple Inc. (NASDAQ: AAPL) had its price target raised by analysts at JPMorgan Chase & Co. from $190.00 to $235.00. They now have an "overweight" rating on the stock.
Ratings data for AAPL provided by MarketBeat
Apple Inc. (NASDAQ: AAPL) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $195.00 price target on the stock.
Ratings data for AAPL provided by MarketBeat
Apple Inc. (NASDAQ: AAPL) had its "buy" rating re-affirmed by analysts at Citigroup Inc.. They now have a $240.00 price target on the stock.
Ratings data for AAPL provided by MarketBeat
Apple Inc. (NASDAQ: AAPL) had its price target raised by analysts at Raymond James from $180.00 to $200.00. They now have an "outperform" rating on the stock.
Ratings data for AAPL provided by MarketBeat
Apple Inc. (NASDAQ: AAPL) had its price target lowered by analysts at Jefferies Financial Group Inc. from $225.00 to $220.00. They now have a "buy" rating on the stock.
Ratings data for AAPL provided by MarketBeat
Apple Inc. (NASDAQ: AAPL) had its price target raised by analysts at Oppenheimer Holdings Inc. from $195.00 to $220.00. They now have an "outperform" rating on the stock.
Ratings data for AAPL provided by MarketBeat
Apple Inc. (NASDAQ: AAPL) had its price target raised by analysts at Canaccord Genuity Group Inc. from $185.00 to $205.00. They now have a "buy" rating on the stock.
Ratings data for AAPL provided by MarketBeat
Apple Inc. (NASDAQ: AAPL) had its price target raised by analysts at Wedbush from $220.00 to $230.00. They now have an "outperform" rating on the stock.
Ratings data for AAPL provided by MarketBeat
Apple Inc. (NASDAQ: AAPL) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $230.00 price target on the stock.
Ratings data for AAPL provided by MarketBeat
Apple Inc. (NASDAQ: AAPL) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $195.00 price target on the stock.
Ratings data for AAPL provided by MarketBeat
Apple Inc. (NASDAQ: AAPL) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $230.00 price target on the stock.
Ratings data for AAPL provided by MarketBeat
Apple Inc. (NASDAQ: AAPL) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $195.00 price target on the stock.
Ratings data for AAPL provided by MarketBeat
Apple Inc. (NASDAQ: AAPL) had its price target raised by analysts at Wedbush from $230.00 to $240.00. They now have an "outperform" rating on the stock.
Ratings data for AAPL provided by MarketBeat
Neueste Beiträge
Oppenheimer_Holdings in United Therapeutics diskutieren